From CBC News:
Health Canada has received new information about an antiviral hepatitis medication suggesting the drug may have been tied to the onset of a treatment-resistant strain of HIV in one patient with the disease.
Entecavir, which is sold under the brand name Baraclude, was authorized for use in Canada in June 2006 to treat hepatitis B in adults. ...more
Thursday, February 22, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment